These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21676885)

  • 1. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
    Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
    Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
    Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
    Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
    Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
    Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
    Wynendaele J; Böhnke A; Leucci E; Nielsen SJ; Lambertz I; Hammer S; Sbrzesny N; Kubitza D; Wolf A; Gradhand E; Balschun K; Braicu I; Sehouli J; Darb-Esfahani S; Denkert C; Thomssen C; Hauptmann S; Lund A; Marine JC; Bartel F
    Cancer Res; 2010 Dec; 70(23):9641-9. PubMed ID: 21084273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.
    Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y
    Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells.
    Zhao H; Zhu L; Jin Y; Ji H; Yan X; Zhu X
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):177-82. PubMed ID: 22172490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
    Zhang S; Chen H; Zhao X; Cao J; Tong J; Lu J; Wu W; Shen H; Wei Q; Lu D
    Oncogene; 2013 Jan; 32(2):242-50. PubMed ID: 22349819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
    Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
    Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility.
    Jiang Y; Qin Z; Hu Z; Guan X; Wang Y; He Y; Xue J; Liu X; Chen J; Dai J; Jin G; Ma H; Wang S; Shen H
    Carcinogenesis; 2013 Mar; 34(3):689-93. PubMed ID: 23188672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations.
    Zu Y; Ban J; Xia Z; Wang J; Cai Y; Ping W; Sun W
    Biochem Biophys Res Commun; 2013 Jan; 430(2):529-34. PubMed ID: 23232114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
    Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
    Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
    Gao F; Xiong X; Pan W; Yang X; Zhou C; Yuan Q; Zhou L; Yang M
    PLoS One; 2015; 10(8):e0135647. PubMed ID: 26274820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
    Hu Z; Xu L; Shao M; Yuan J; Wang Y; Wang F; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jing G; Huo X; Chen F; Jin L; Wei Q; Wu T; Lu D; Huang W; Shen H
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
    Liu ME; Liao YC; Lin RT; Wang YS; Hsi E; Lin HF; Chen KC; Juo SH
    Atherosclerosis; 2013 May; 228(1):161-7. PubMed ID: 23497787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population.
    Hu Z; Miao X; Ma H; Wang X; Tan W; Wei Q; Lin D; Shen H
    Lung Cancer; 2005 Apr; 48(1):11-7. PubMed ID: 15777967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
    Hu H; Zhang L; Teng G; Wu Y; Chen Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
    Xiong J; Du Q; Liang Z
    Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis.
    Yu D; Zhang X; Liu J; Yuan P; Tan W; Guo Y; Sun T; Zhao D; Yang M; Liu J; Xu B; Lin D
    Clin Cancer Res; 2008 May; 14(9):2878-86. PubMed ID: 18451256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer.
    Yoon KA; Hwangbo B; Kim IJ; Park S; Kim HS; Kee HJ; Lee JE; Jang YK; Park JG; Lee JS
    Carcinogenesis; 2006 Nov; 27(11):2217-22. PubMed ID: 16774942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.